Brett Fishman
Analyst, KeyBank
Replay available
Sotera Health Company (NASDAQ: SHC) Q2 2025 earnings conference call, held 2025-08-08. Replay captured from the company's public earnings webcast.

Analyst, KeyBank
Analyst, J.P. Morgan
Vice President and Treasurer
Analyst, Barclays
Analyst, Jefferies
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, Citi
Analyst, Piper Sandler
Good morning and welcome to the Zotero Health second quarter 2025 conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's remarks, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Vice President and Treasurer Jason Peterson. Please go ahead. Good morning and thank you. Welcome to Sotera Health second quarter 2025 earnings call. You can find today's press release and accompanying supplemental slides on the investor section of our website at soterahealth.com. This webcast is being recorded and a replay will be available in the investor section of the Sotera Health website. On the call with me today are Chairman and Chief Executive Officer Michael Petras and Chief Financial Officer John Lyons. During the call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Cetera Health's SEC filings in the forward-looking statement slide at the beginning of this presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements. Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, tax rate applicable to net income, adjusted net income, adjusted EPS, net debt an...